The relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria

Journal of Blood Medicine

Volumn 5, Issue , 2014, Pages 185-189

  Dada, Olusola Akinola ^a   Uche, Ebele ^a   Akinbami, Akinsegun ^a   Odesanya, Majeed ^b   John Olabode, Sarah ^c   Adediran, Adewumi ^d   Oshinaike, Olajumoke ^a   Ogbera, Anthonia Okeoghene ^a   Okunoye, Olaitan ^e   Arogundade, Olanrewaju ^a   Aile, Kingsley ^f   Ekwere, Timothy ^g  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b Oak Specialist Hospital   (Nigeria)

^c BABCOCK UNIVERSITY   (Nigeria)

^d UNIVERSITY OF LAGOS   (Nigeria)

^e UNIVERSITY OF PORT HARCOURT   (Nigeria)

^f LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^g UNIVERSITY OF UYO   (Nigeria)

Author keywords

Fasting blood sugar; RDW; Type 2 DM

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RED BLOOD CELL DISTRIBUTION WIDTH;

EID: 84924981234     PISSN: None     EISSN: 11792736     Source Type: Journal    
DOI: 10.2147/JBM.S67989     Document Type: Article

References (33)

1. American Diabetes Association. Diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2011;34(Suppl 1):S62–S69.
2. Dangei G, Finucane MM, Lu Y, et al. National, Regional and Global trends in Fasting Plasma Glucose and Diabetes prevalence since 1980; systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLOS Med. 2006;3(11):e442.
4. Global Status report on non-communicable diseases 2010. WHO, 2011;176.
5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and class of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197.
6. Pickup JC, Crook MA. Is Type 2 Diabetes Mellitus a disease of the innate immune system? Diabetologia. 1998;41:1241–1248.
7. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: Association of acute phase reactants and IL-6 with Metabolic Syndrome. Diabetologia. 1997;40: 1286–1292.
8. King GK. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79:1527–1534.
9. Larsen GL, Henson PM. Mediators of inflammation. Annu Rev Immunol. 1983;1:335–359.
10. Evans T, Jehle D. The red blood cell distribution width. J Emmerg Med. 1991;9(1):71–74.
11. Tesfamarin B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263: 321–326.
12. King GL, Loekan MR. Hyperglycaemia-induced oxidative stress in diabetic complications. Histochem Cell Biol. 2004;122:333–338.
13. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure; data from the CHARM programme and the Duke Databank. J Am Coll Cardiol. 2007;50:40–47.
14. Tonellim M, Sacks F, Arnold M, et al. Relation between red cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163–165.
15. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advance heart failure: An analysis of the cytokine databse from the vesnarinone trial (VEST). Circulation. 2001;103:2055–2059.
16. Chiari MM, Bagnoli R, De Luca PD, Monti M, Rampoldi E, Cunietti E. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc. 1995;43:767–771.
17. Pierce C, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical device. Perfusion. 2005;20:83–90.
18. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community based prospective cohort. Arch Intern Med. 2009;169:588–590.
19. Yeşil A, Şenateş E, Bayoğlu IV, et al. Red cell distribution width: A novel marker of activity in inflammatory bowel disease. Gut liver. 2011;5(4):460–467.
20. Malandrino N, Wu WC, Taveira TH, Whtlach HB, Smith RJ. Association between red blood cell distribution width and macrovascular complications in diabetes. Diabetologica. 2012;55:226–235.
21. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med. 1991;9(1):71–74.
22. Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, et al. Proinflammatory State and circulating erythropoiesis in persons with or without anaemia. Am J Med. 2005;118(11):1288. e11–1288. e19.
23. Weiss G, Goodnough LT. Anaemia of chronic disease. N Engl J Med. 2005;352:1011–1023.
24. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009;169:515–523.
25. Araneta MR, Grandinetti A, Chang HK. A1C and Diabetes Diagnosis Among Filipino American, Japanese Americans and Native Hawaiians. Diabetes Care. 2010:33(12):2626–2628.
26. Lee YH, Partley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70–75.
27. Sherif H, Ramadan N, Radwan M, Hamdy E, Reda R. Red Cell Distribution Width as a Marker of Inflammation in Type 2 Diabetes Mellitus. Life Sci J. 2013;10(3):1501–1507.
28. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure, data from CHARM program and Duke data bank. J Am Coll Cardiol. 2007;50:40–47.
29. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M; for the cholesterol and recurrent events (CARE) Trial Investigators. Relation between red blood cells distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117(2): 163–168.
30. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010;105:312–317.
31. Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potentials circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011;97:1054–1060.
32. Ye Z, Smith C, Kullo IJ. Usefulness of red cell distribution width to predict mortality in patients with peripheral arterial disease Am J Cardiol. 2011;107:1241–1245.
33. Shuta Tsuboi, katsumi Miyauchi, Takatoshi Kasai, Manabu Ogita, Tomotaka Doli, et al. Impact of Red Blood Cell Distribution Width on long term mortality in Diabetic patients after percutaneous coronary intervention. Circulation Journal. 2013;77:456–461.